Manufacturing and Production

Showing 15 posts of 5871 posts found.

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Deepak Khanna becomes new ABPI president-elect

December 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

Biogen and Samsung invest $300m on joint biosimilars venture

December 8, 2011 Manufacturing and Production Biogen, Samsung, biosimilars

Biogen Idec and Samsung will invest $300 million in a joint venture to develop biosimilars. Both firms will contribute a …

New EU Cosmetics Regulation

December 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …
Lonza picture

Lonza to make Elan’s Alzheimer’s candidate

December 7, 2011 Manufacturing and Production Abbott, Elan, Lonza

Elan has awarded a manufacturing contract to Lonza to supply the active pharmaceutical ingredient (API) for its small-molecule candidate Alzheimer’s …

Contract research news in brief

December 7, 2011 Manufacturing and Production Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …

Catalent Announces plans to increase Biologic Development and Manufacturing Capabilities

December 7, 2011 Manufacturing and Production

SOMERSET, NJ, December 7, 2011 — Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies …

Health Protection Agency welcomes the Approval of ERWINAZEâ„¢ Biologics License Application for Treatment of Acute Lymphoblastic Leukemia

December 7, 2011 Manufacturing and Production

Salisbury, UK – 18th November 2011 –the Health Protection Agency (HPA) today welcomed the news that the U.S. Food and …

GlaxoSmithKline moves closer to green power goals

December 6, 2011 Manufacturing and Production GSK, manufacturing

GlaxoSmithKline took a step closer to becoming a generator of electricity in a bid to offset the high energy demands …

Pharma manufacturing news in brief

December 6, 2011 Manufacturing and Production GSK, Hospira, PharmaS, UPS, Uquifa, Vivimed

India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …

SciGen sells Israeli vaccines plant to FDS

December 6, 2011 Manufacturing and Production FDS, SciGen

UK drugmaker FDS Pharma has bought a manufacturing facility in Israel operated by Singapore biopharmaceutical concern SciGen. FDS Pharma has …

Actavis buys packager to boost manufacturing efficiencies

December 6, 2011 Manufacturing and Production Actavis, pharmapack

Generic drugmaker Actavis has acquired Netherlands-based company PharmaPack International in a bid to cut its lead times for packaging and …
lamattinalee

Big pharma: big rewards come from big risks

December 5, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

Astellas adds two senior executives at US site

December 5, 2011 Business Services, Manufacturing and Production, Sales and Marketing Astellas

Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …
Boehringer picture

Boehringer will help develop Aveo’s lung cancer candidate

December 2, 2011 Manufacturing and Production

Boehringer Ingelheim has agreed to help oncology specialist firm Aveo develop its lung cancer treatment ficlatuzumab.  The agreement is for …
The Gateway to Local Adoption Series

Latest content